|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.82 EUR | +1.34% |
|
+0.17% | -7.24% |
| 05-13 | Spanish stocks - Factors to watch on May 13 | RE |
| 05-09 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 22.2x | 3.93x | -4.53x | 3.81x | 14.43x | 17.17x | 1.68% | 3.42B | ||
| 33.97x | 20.27x | 0.69x | 12.34x | 25.42x | 25.92x | 0.59% | 1,035B | ||
| 25.47x | 6.41x | -1.68x | 5.87x | 15.96x | 17.65x | 2.24% | 574B | ||
| 27.52x | -818.21x | 0.11x | 6.71x | 13.7x | 14.08x | 3.05% | 397B | ||
| 17.45x | 6.43x | 1.08x | 4.31x | 10.59x | 11.95x | 3.08% | 324B | ||
| 22.84x | 5.29x | 1.07x | 4.75x | 13.5x | 14.15x | 1.84% | 281B | ||
| 21.11x | 6.3x | -131.19x | 5.44x | 13.22x | 14.42x | 2.98% | 278B | ||
| 12.49x | 5.46x | -6.93x | 4.69x | 9.58x | 11.25x | 4.02% | 193B | ||
| 23.02x | 17.17x | 2.85x | 6.15x | 10.74x | 14.07x | 2.85% | 191B | ||
| -45.04x | 8.55x | 0.32x | 5.44x | 30.73x | 60.94x | 2.58% | 156B | ||
| 12.24x | 1.7x | 0.21x | 3.2x | 7.79x | 9.06x | 6.7% | 149B | ||
| 11.15x | 4.93x | 0.23x | 3.06x | 8.18x | 8.89x | 4.42% | 116B | ||
| 25.45x | 5.11x | 1.8x | 7.68x | 17.33x | 18.04x | -.--% | 113B | ||
| 11.37x | 1.22x | 2.35x | 2.2x | 7.12x | 8.08x | 5.58% | 106B | ||
| 12.64x | 4.66x | 1.26x | 2.74x | 8.06x | 9.08x | 3.56% | 105B | ||
| 23.93x | 5.44x | 1.35x | 8.15x | 15.4x | 16.11x | 1.84% | 76.18B | ||
| 44.79x | 1.12x | 0.7x | 2.62x | 9.68x | 27.46x | 3.97% | 49.55B | ||
| 33.39x | 4.51x | 1.74x | 7.38x | 24.5x | 25.33x | 0.58% | 45.85B | ||
| 15.31x | 1.24x | -0.09x | 1.47x | 6.97x | 11.64x | 0.62% | 40.52B | ||
| 17.44x | 1.74x | 4.92x | 3.2x | 12.09x | 13.55x | 2.38% | 39.48B | ||
| Average | 18.44x | -35.34x | -6.19x | 5.06x | 13.75x | 17.44x | 2.73% | 213.66B | |
| Weighted average by Cap. | 21.97x | -67.03x | -8.37x | 6.90x | 16.33x | 18.68x | 2.37% |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















